Lipopeptide Antibiotics: How Daptomycin and the Polymyxins Attack Bacterial Membranes

Lipopeptides are antibiotics built on a simple, powerful idea: attach a fatty (lipid) tail to a peptide ring, and you get a molecule that inserts into and disrupts bacterial membranes. The lipid tail acts like an anchor that buries into the membrane's oily interior, while the peptide provides the specificity and the disruptive punch. This class includes drugs for the two great divisions of bacteria — Gram-positive and Gram-negative — and some of the most important last-resort antibiotics in medicine.

Two families, two targets

The lipopeptide antibiotics used clinically fall into two main groups that attack different bacteria:

• Daptomycin — targets Gram-positive bacteria, including MRSA.
• The polymyxins — colistin and polymyxin B — target Gram-negative bacteria, including multidrug-resistant organisms.

Both work on the membrane, but through distinct chemistry suited to each cell type.

Daptomycin: depolarizing the Gram-positive membrane

Daptomycin is a cyclic lipopeptide that inserts into the Gram-positive cell membrane in a calcium-dependent way, forming aggregates that punch through and cause rapid depolarization — the membrane's electrical gradient collapses, and essential processes fail. Because it kills by physically disrupting the membrane rather than blocking a single enzyme, resistance is relatively slow to develop.

A crucial clinical quirk follows from its mechanism: daptomycin does not work in the lungs. Pulmonary surfactant — the substance that keeps the air sacs open — binds and inactivates the drug. So despite being excellent for MRSA bloodstream infections and endocarditis, daptomycin cannot treat pneumonia. It's a textbook example of why antibiotic choice depends on the site of infection.

The polymyxins: cracking the Gram-negative outer membrane

The polymyxins attack the feature that makes Gram-negative bacteria so hard to treat — their outer membrane. This membrane is studded with lipopolysaccharide (LPS), whose lipid A component is negatively charged. The positively charged polymyxin ring is drawn to lipid A, and the fatty tail inserts into the membrane, displacing stabilizing cations (magnesium and calcium) and destabilizing the whole envelope in a detergent-like way. The membrane becomes leaky, and the bacterium dies.

Because they target the outer membrane directly, polymyxins retain activity against Gram-negatives resistant to almost everything else — which is why colistin and polymyxin B have returned as last-resort drugs for carbapenem-resistant infections.

The toxicity trade-off

Membrane-disrupting power comes at a cost. The polymyxins were largely abandoned for decades because of nephrotoxicity (kidney injury) and neurotoxicity, and they came back only because resistance left few alternatives. They're also pharmacologically tricky — colistin is given as an inactive prodrug (colistimethate) that must be converted in the body, historically causing underdosing. Modern practice uses loading doses and careful monitoring. Daptomycin is better tolerated but can affect muscle (monitored via creatine kinase).

Resistance and the mcr gene

A major modern concern is transferable colistin resistance carried by the mcr genes (first identified as mcr-1). Because these sit on mobile plasmids, they can spread between bacteria and species, threatening one of the last lines of defense against resistant Gram-negatives. It's a leading reason for stewardship of the polymyxins.

Related membrane-active peptides

Other peptide antibiotics also work on membranes or the wall, including topical agents like bacitracin and the channel-forming gramicidin, and the body's own antimicrobial peptides such as LL-37 and the defensins.

The takeaway

Lipopeptides marry a fatty tail to a peptide to disrupt bacterial membranes — daptomycin for Gram-positives, the polymyxins for Gram-negatives. Their mechanisms explain their strengths (activity against resistant organisms), their quirks (daptomycin's uselessness in the lung), and their limits (polymyxin toxicity and the spread of mcr resistance). They are among the most consequential antibiotics we have, precisely because they still work when other drugs have failed.

This article is educational and does not constitute medical advice. Antibiotics are prescription medicines used under professional guidance.